生物技术进展 ›› 2016, Vol. 6 ›› Issue (4): 277-282.DOI: 10.3969/j.issn.2095-2341.2016.04.10

• 研究论文 • 上一篇    下一篇

N-糖链切除对重组抗狂犬病毒单克隆抗体中和活性的影响

吕若芸§,王辉§,陈忱,张世雄,张晓楠,曹晨华,魏敬双*   

  1. 华北制药集团新药研究开发有限责任公司, 抗体药物研制国家重点实验室, 石家庄 050015
  • 收稿日期:2016-05-18 出版日期:2016-07-25 发布日期:2016-06-12
  • 通讯作者: 魏敬双,正高级工程师,研究方向为生物技术药物研发。E-mail:weijsh@hotmail.com
  • 作者简介:§吕若芸与王辉为本文共同第一作者。 吕若芸,工程师,研究方向为单抗药物纯化与质量研究。E-mail:lvry2010@163.com。王辉,工程师,研究方向为单抗药物纯化与质量研究。E-mail:whui@163.com。
  • 基金资助:

    “十二五”国家科技重大专项(2014ZX09201041)资助。

Effect of the N-glycan Removal on the Neutralization Activity of Recombinant Anti-rabies Monoclonal Antibodies

LV Ruo-yun, WANG Hui,  CHEN Chen, ZHANG Shi-xiong, ZHANG Xiao-nan, CAO Chen-hua, WEI Jing-shuang   

  1. State Key Laboratory of Antibody Research & Development, New Drug Research and Development Company Ltd., North
    China Pharmaceutical Corporation, Shijiazhuang 050015, China
  • Received:2016-05-18 Online:2016-07-25 Published:2016-06-12

摘要: 重组抗狂犬病毒单克隆抗体是一种全人源的抗病毒感染单抗,主要用于狂犬病毒暴露后预防。采用糖苷酶处理2种重组抗狂犬 病毒单克隆抗体Mab1、Mab2水解切除N-糖链,通过糖染色和毛细管电泳检测确定N-糖链酶解程度,利用快速荧光灶抑制试验检 测其中和活性,分析N-糖链切除对该单抗中和活性的影响。结果显示,N-糖链切除后抗体中和活性无明显变化。说明N-糖链对 这两株抗狂犬病毒单抗的体外中和活性不是必须的结构成分。

关键词: 重组抗狂犬病毒单克隆抗体, N-糖链切除, 毛细管电泳, 中和活性

Abstract: The recombinant anti-rabies monoclonal antibody were fully-human-derived antibody and were used for post- explosure prophylaxis of rabies virus. The N-glycan of two anti-rabies monoclonal antibodies (Mab1 and Mab2) were hydrolyzed by the PNGase in this study, the capillary electrophoresis and gel staining by periodic acid- schiff method were used to determine the residual N-glycan after hydrolysis. The rapid fluorescent focus inhibition test was used to compare the neutralization bio-activity of the intact Mab1 and the Mab2 without N-glycan. The result showed that the neutralization bioactivity of  Mab1 and Mab2 did not change after the N- glycan was removed from the antibodies. That suggests the N-glycan was not the indispensable composition for in-vitro neutralization bioactivity of Mab1 and Mab2.

Key words:

activity